Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

alteplase

alteplase
  • Formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Cathflo Activase POWDER FOR INJECTION, INJECTABLE 2 mg      
Activase POWDER FOR INJECTION, INTRAVENOUS 50 mg, 100 mg      
VIEW MORE Thrombolytic Agents
Comments:

TPA for catheter de-clotting 2 mg/2 ml.

alteplase (tpa) and dornase alfa for intrapleural use

 

Acute Ischemic Stroke (AIS) Considerations: Tenecteplase is the preferred fibrinolytic for AIS. [Tentative Go-Live February 1, 2024]

 

Updated: December 2023 (AIS Indication)

Alteplase to Tenecteplase Update

Last updated: Aug. 15, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved